{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:41:12Z","timestamp":1790948472189,"version":"4.1.0"},"reference-count":115,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T00:00:00Z","timestamp":1456444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0149631","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T18:43:49Z","timestamp":1456512229000},"page":"e0149631","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Medical Therapies for Uterine Fibroids \u2013 A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials"],"prefix":"10.1371","volume":"11","author":[{"given":"Kurinchi S.","family":"Gurusamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian S.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence M. J.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,26]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/EDE.0b013e31828acca0","article-title":"Vitamin d and the risk of uterine fibroids","volume":"24","author":"DD Baird","year":"2013","journal-title":"Epidemiology"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.fertnstert.2013.02.017","article-title":"Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18\u201330 years old): a pilot study","volume":"99","author":"EE Marsh","year":"2013","journal-title":"Fertility and sterility"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/jwh.2011.3008","article-title":"Self-report versus ultrasound measurement of uterine fibroid status","volume":"21","author":"SL Myers","year":"2012","journal-title":"Journal of women's health"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6874-12-6","article-title":"Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women","volume":"12","author":"A Zimmermann","year":"2012","journal-title":"BMC women's health"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"DD Baird","year":"2003","journal-title":"American journal of obstetrics and gynecology"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.fertnstert.2012.10.039","article-title":"Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy","volume":"99","author":"PG Moorman","year":"2013","journal-title":"Fertility and sterility"},{"key":"ref7","article-title":"Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations","author":"JH Segars","year":"2014","journal-title":"Human reproduction update"},{"issue":"14","key":"ref8","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"SE Bulun","year":"2013","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/jsm.12425","article-title":"Examining the relationship between uterine fibroids and dyspareunia among premenopausal women in the United States","volume":"11","author":"M Moshesh","year":"2014","journal-title":"The journal of sexual medicine"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"38.e1","DOI":"10.1016\/j.ajog.2013.09.038","article-title":"Submucosal fibroids and the relation to heavy menstrual bleeding and anemia","volume":"210","author":"K Puri","year":"2014","journal-title":"American journal of obstetrics and gynecology"},{"issue":"4","key":"ref11","first-page":"289","article-title":"Fibroids in infertility\u2014consensus statement from ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence)","volume":"51","author":"B Kroon","year":"2011","journal-title":"The Australian & New Zealand journal of obstetrics & gynaecology"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ajog.2012.01.046","article-title":"The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them?","volume":"207","author":"MG Munro","year":"2012","journal-title":"American journal of obstetrics and gynecology"},{"issue":"2\u20133","key":"ref13","first-page":"111","article-title":"Fibroid volume, location and symptoms in women undergoing uterine artery embolization: does size or position matter?","volume":"52","author":"EK Arleo","year":"2007","journal-title":"International journal of fertility and women's medicine"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"319 e1","DOI":"10.1016\/j.ajog.2013.07.017","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"209","author":"BJ Borah","year":"2013","journal-title":"American journal of obstetrics and gynecology"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/jwh.2008.0456","article-title":"What are the total costs of surgical treatment for uterine fibroids?","volume":"17","author":"GS Carls","year":"2008","journal-title":"Journal of women's health"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"211 e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"ERC, A.D. Cardozo","year":"2012","journal-title":"American journal of obstetrics and gynecology"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/GRF.0000000000000004","article-title":"Prevention and management of hysterectomy complications","volume":"57","author":"KR Hodges","year":"2014","journal-title":"Clinical obstetrics and gynecology"},{"key":"ref18","first-page":"CD009505","article-title":"Aromatase inhibitors for uterine fibroids","volume":"10","author":"H Song","year":"2013","journal-title":"The Cochrane database of systematic reviews"},{"key":"ref19","first-page":"CD005287","article-title":"Selective estrogen receptor modulators (SERMs) for uterine leiomyomas","volume":"10","author":"L Deng","year":"2012","journal-title":"The Cochrane database of systematic reviews"},{"key":"ref20","first-page":"CD007687","article-title":"Mifepristone for uterine fibroids","volume":"8","author":"M Tristan","year":"2012","journal-title":"The Cochrane database of systematic reviews"},{"key":"ref21","first-page":"285","article-title":"Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids","volume":"8","author":"N Biglia","year":"2014","journal-title":"Drug design, development and therapy"},{"issue":"2","key":"ref22","first-page":"CD000547","article-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","author":"A Lethaby","year":"2001","journal-title":"The Cochrane database of systematic reviews"},{"issue":"7506","key":"ref23","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/bmj.330.7506.1478","article-title":"Methods of hysterectomy: systematic review and meta-analysis of randomised controlled trials","volume":"330","author":"N Johnson","year":"2005","journal-title":"Bmj"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"G Salanti","year":"2011","journal-title":"Journal of clinical epidemiology"},{"key":"ref25","article-title":"The Cochrane Collaboration","author":"J Higgins","year":"2011"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"ref27","unstructured":"Dias S, Welton N, Sutton A, Ades A. NICE DSU Technical Support Document 1: Introduction to evidence synthesis for decision making. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/wwwnicedsuorguk\/TSD1%20Introductionfinal080512pdf\" xlink:type=\"simple\">http:\/\/wwwnicedsuorguk\/TSD1%20Introductionfinal080512pdf<\/ext-link>. 2012 (Accessed 11 March 2014)."},{"issue":"7109","key":"ref28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"Bmj"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"GH Guyatt","year":"2011","journal-title":"Journal of clinical epidemiology"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.fertnstert.2004.12.058","article-title":"Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women","volume":"84","author":"S Palomba","year":"2005","journal-title":"Fertility and sterility"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0378-5122(98)00014-0","article-title":"Bleeding patterns in recent postmenopausal outpatients with uterine myomas: Comparison between two regimens of HRT","volume":"29","author":"D De Aloysio","year":"1998","journal-title":"Maturitas"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"ED Levens","year":"2008","journal-title":"Obstetrics and gynecology"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0015-0282(98)00128-9","article-title":"A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata","volume":"70","author":"S Palomba","year":"1998","journal-title":"Fertility and sterility"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejogrb.2006.07.042","article-title":"A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women","volume":"135","author":"YB Baytur","year":"2007","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"8","key":"ref35","first-page":"1024","article-title":"Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth Histologic, sonographic, and intra-operative changes","volume":"30","author":"M Sayyah-Melli","year":"2009","journal-title":"Saudi Med J"},{"issue":"3","key":"ref36","first-page":"445","article-title":"Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression","volume":"28","author":"MS Melli","year":"2007","journal-title":"Saudi Med J"},{"issue":"Suppl 10","key":"ref37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1471-0528.1994.tb13683.x","article-title":"Deferred versus immediate surgery for uterine fibroids: clinical trial results","volume":"101","author":"AJ Audebert","year":"1994","journal-title":"British journal of obstetrics and gynaecology"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0015-0282(02)03093-5","article-title":"Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium","volume":"77","author":"J van de Ven","year":"2002","journal-title":"Fertility and sterility"},{"key":"ref39","first-page":"95A","article-title":"Does the selective progesterone receptor modulator ulipristal normalize the uterine cavity in women with leiomyoma","volume":"1","author":"G Levy","year":"2011","journal-title":"Reproductive Sciences"},{"issue":"2","key":"ref40","first-page":"109","article-title":"Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women. [Czech] Vliv aplikace GnRH analog na peroperacni a postoperacni vysledky myomektomie u zen v reprodukcnim veku","volume":"77","author":"R Hudecek","year":"2012","journal-title":"Ceska Gynekologie"},{"key":"ref41","first-page":"S78","article-title":"Effect of low dose mifepristone on uterine leiomyoma in reproductive age group","volume":"1","author":"N Varun","year":"2013","journal-title":"Fertility and sterility"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000243776.23391.7b","article-title":"Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial","volume":"108","author":"K Fiscella","year":"2006","journal-title":"Obstetrics and gynecology"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0378-5122(97)00036-4","article-title":"Effect of tibolone on postmenopausal women with myomas","volume":"27","author":"O Gregoriou","year":"1997","journal-title":"Maturitas"},{"key":"ref44","first-page":"i90","article-title":"Effect of ulipristal acetate, a selective progesterone receptor modulator (SPRM), on fibroid size in women with symptomatic uterine fibroids","volume":"25","author":"A Armstrong","year":"2010","journal-title":"Human Reproduction"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/humrep\/17.12.3213","article-title":"Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial","volume":"17","author":"S Palomba","year":"2002","journal-title":"Human reproduction (Oxford, England)"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0015-0282(00)01676-9","article-title":"Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy","volume":"75","author":"S Palomba","year":"2001","journal-title":"Fertility and sterility"},{"issue":"11","key":"ref47","first-page":"421","article-title":"Effects of hormone replacement therapy on postmenopausal women with uterine fibroids","volume":"51","author":"G Orsini","year":"1999","journal-title":"Minerva Ginecologica"},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0002-9378(94)70332-9","article-title":"The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study","volume":"170","author":"RC Reinsch","year":"1994","journal-title":"American journal of obstetrics and gynecology"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/humrep\/dem026","article-title":"The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata","volume":"22","author":"AR Williams","year":"2007","journal-title":"Human reproduction (Oxford, England)"},{"issue":"12","key":"ref50","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1210\/jc.2008-1104","article-title":"Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy","volume":"93","author":"J Wilkens","year":"2008","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2010.09.059","article-title":"Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study","volume":"95","author":"LK Nieman","year":"2011","journal-title":"Fertility and sterility"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2007.02.064","article-title":"Efficacy of tibolone as &quot;add-back therapy&quot; in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids","volume":"89","author":"EP Morris","year":"2008","journal-title":"Fertility and sterility"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.fertnstert.2012.07.351","article-title":"Efficacyof ulipristal acetate forthe treatment of symptomatic uterine leiomyomas in African Americans","volume":"1","author":"LJ Green","year":"2012","journal-title":"Fertility and sterility"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"AR Williams","year":"2012","journal-title":"International journal of gynecological pathology: official journal of the International Society of Gynecological Pathologists"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0015-0282(16)53276-2","article-title":"Fasting serum growth hormone and insulin-like growth factor-I and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo","volume":"53","author":"AJ Friedman","year":"1990","journal-title":"Fertility and sterility"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0029-7844(95)00102-W","article-title":"GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: A randomized controlled trial","volume":"86","author":"TG Stovall","year":"1995","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1074-3804(05)60254-X","article-title":"GnRH agonist treatment before total laparoscopic hysterectomy for large uteri","volume":"10","author":"R Seracchioli","year":"2003","journal-title":"J Am Assoc Gynecol Laparoscopists"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.fertnstert.2009.05.070","article-title":"GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study","volume":"94","author":"L Muzii","year":"2010","journal-title":"Fertility and sterility"},{"issue":"2","key":"ref59","first-page":"63","article-title":"GnRH analogues and laparoscopic myomectomy","volume":"9","author":"E Zullo","year":"1997","journal-title":"Italian Journal of Gynaecology and Obstetrics"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.fertnstert.2008.02.128","article-title":"Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial","volume":"91","author":"CC Coddington","year":"2009","journal-title":"Fertility and sterility"},{"issue":"6","key":"ref61","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0015-0282(03)00362-5","article-title":"Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: A controlled trial","volume":"79","author":"P Vercellini","year":"2003","journal-title":"Fertility and sterility"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/S0002-9378(94)70350-7","article-title":"Gonadotropin-releasing hormone agonist use before hysterectomy","volume":"170","author":"TG Stovall","year":"1994","journal-title":"American journal of obstetrics and gynecology"},{"issue":"8","key":"ref63","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.clinthera.2007.08.024","article-title":"Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: Results from a phase III, randomized, multicenter, double-blind, controlled trial","volume":"29","author":"O Muneyyirci-Delale","year":"2007","journal-title":"Clin Ther"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-2115(99)00089-5","article-title":"Goserelin acetate to avoid hysterectomy in pre-menopausal women with fibroids requiring surgery","volume":"87","author":"F Parazzini","year":"1999","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"2","key":"ref65","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijgo.2007.10.020","article-title":"Goserelin versus leuprolide before hysterectomy for uterine fibroids","volume":"101","author":"SS Lim","year":"2008","journal-title":"Int J Gynecol Obstet"},{"issue":"3","key":"ref66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0378-5122(02)00081-6","article-title":"Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system","volume":"42","author":"T Simsek","year":"2002","journal-title":"Maturitas"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0028-2243(91)90207-2","article-title":"Intranasal buserelin versus surgery in the treatment of uterine leiomyomata: long-term follow-up","volume":"38","author":"L Fedele","year":"1990","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"ref68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/humrep\/14.1.44","article-title":"Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotrophin-releasing hormone analogues","volume":"14","author":"S Campo","year":"1999","journal-title":"Human Reproduction"},{"issue":"1","key":"ref69","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2009.02.006","article-title":"Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: Relationship between clinical features and immunohistochemical changes","volume":"144","author":"M De Falco","year":"2009","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0015-0282(16)56177-9","article-title":"Leuprolide acetate depot decreases the number of nucleolar organizer regions in uterine leiomyomata","volume":"60","author":"RL Barbieri","year":"1993","journal-title":"Fertility and sterility"},{"issue":"3","key":"ref71","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0029-7844(95)00191-S","article-title":"Leuprolide acetate treatment and myoma arterial size","volume":"86","author":"JL Rutgers","year":"1995","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0301-2115(99)00168-2","article-title":"Leuprorelin depot 3.75 mg versus lynestrenol in the preoperative treatment of symptomatic uterine myomas: a multicentre randomised trial","volume":"89","author":"E Verspyck","year":"2000","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"Suppl 6","key":"ref73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/gye.15.s6.61.68","article-title":"Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs","volume":"15","author":"J van de Ven","year":"2001","journal-title":"Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology"},{"issue":"2","key":"ref74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/humrep\/deh053","article-title":"Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene","volume":"19","author":"S Palomba","year":"2004","journal-title":"Human Reproduction"},{"issue":"1","key":"ref75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1479-828X.2008.00931.x","article-title":"Low-dose mifepristone in treatment of uterine leiomyoma: A randomised double-blind placebo-controlled clinical trial","volume":"49","author":"M Bagaria","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"ref76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0028-2243(90)90096-J","article-title":"Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: Analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot","volume":"37","author":"S Constantini","year":"1990","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"1","key":"ref77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2508.2001.00396.x","article-title":"Management of uterine fibroids with goserelin acetate alone or goserelin acetate plus endometrial resection","volume":"10","author":"M Rees","year":"2001","journal-title":"Gynaecological Endoscopy"},{"issue":"8","key":"ref78","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/humrep\/dep100","article-title":"Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial","volume":"24","author":"M Engman","year":"2009","journal-title":"Human reproduction (Oxford, England)"},{"key":"ref79","first-page":"i70","article-title":"Mifepristone induces myoma volume reduction by regulating genes in the Integrin and Ephrin pathways","volume":"26","author":"S Jo Varghese","year":"2011","journal-title":"Human Reproduction"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/IJWH.S42770","article-title":"Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial","volume":"5","author":"JL Esteve","year":"2013","journal-title":"International journal of women's health"},{"issue":"6","key":"ref81","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000184806","article-title":"The place of Zoladex in deferred surgery for uterine fibroids. Zoladex Myoma Study Group","volume":"45","author":"J Gerris","year":"1996","journal-title":"Hormone research"},{"issue":"Suppl 1","key":"ref82","first-page":"1","article-title":"Placebo-controlled comparison of the effectiveness of buserelin depot formulation in the preoperative management of patients with uterine fibroids","volume":"6","author":"RW Shaw","year":"1997","journal-title":"Gynaecological Endoscopy"},{"issue":"6","key":"ref83","first-page":"856","article-title":"A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata","volume":"74","author":"WD Schlaff","year":"1989","journal-title":"Obstetrics and gynecology"},{"issue":"2","key":"ref84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.steroids.2004.10.008","article-title":"Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern","volume":"70","author":"A Lieto","year":"2005","journal-title":"Steroids"},{"issue":"3","key":"ref85","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/oxfordjournals.humrep.a138070","article-title":"Pre-operative gonadotrophin-releasing hormone agonist treatment in surgery for uterine leiomyomata","volume":"8","author":"A Golan","year":"1993","journal-title":"Human reproduction (Oxford, England)"},{"key":"ref86","first-page":"356","article-title":"Preoperative management of uterine leiomyomatosis using pituitary gonadotropin-releasing hormone analogues. [Spanish] Tratamiento medico preoperatorio de leiomiomatosis uterina con analogos de hormona liberadora de gonadotropinas hipofisarias","volume":"63","author":"HH Bustos Lopez","year":"1995","journal-title":"Ginecologia y obstetricia de Mexico"},{"issue":"2","key":"ref87","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejogrb.2006.07.018","article-title":"Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study","volume":"134","author":"JB Engel","year":"2007","journal-title":"European journal of obstetrics, gynecology, and reproductive biology"},{"issue":"1","key":"ref88","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0002-9378(98)70635-0","article-title":"A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: Efficacy and ultrasonographic predictors","volume":"178","author":"F Zullo","year":"1998","journal-title":"American journal of obstetrics and gynecology"},{"issue":"8","key":"ref89","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/jcem.87.8.8747","article-title":"Raloxifene administration in premenopausal women with uterine leiomyomas: A pilot study","volume":"87","author":"S Palomba","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"10","key":"ref90","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1210\/jc.2002-020780","article-title":"Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism","volume":"87","author":"S Palomba","year":"2002","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"1","key":"ref91","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.fertnstert.2003.06.009","article-title":"Raloxifene prevents the growth of uterine leiomyomas in premenopausal women","volume":"81","author":"S Jirecek","year":"2004","journal-title":"Fertility and sterility"},{"issue":"2","key":"ref92","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"GH Sayed","year":"2011","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"ref93","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0301-2115(99)00115-3","article-title":"A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas","volume":"88","author":"L Fedele","year":"2000","journal-title":"European journal of obstetrics, gynecology, and reproductive biology"},{"issue":"6","key":"ref94","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/0002-9378(91)91419-W","article-title":"A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas","volume":"164","author":"TG Stovall","year":"1991","journal-title":"American journal of obstetrics and gynecology"},{"issue":"1","key":"ref95","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2008.09.064","article-title":"A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status","volume":"93","author":"ME Parsanezhad","year":"2010","journal-title":"Fertility and sterility"},{"issue":"6","key":"ref96","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2006.11.094","article-title":"A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata","volume":"87","author":"K Chwalisz","year":"2007","journal-title":"Fertility and sterility"},{"issue":"3","key":"ref97","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0015-0282(16)59763-5","article-title":"A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri","volume":"49","author":"AJ Friedman","year":"1988","journal-title":"Fertility and sterility"},{"issue":"6","key":"ref98","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0015-0282(03)00261-9","article-title":"A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy","volume":"79","author":"J Donnez","year":"2003","journal-title":"Fertility and sterility"},{"issue":"5","key":"ref99","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0015-0282(16)61022-1","article-title":"A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy","volume":"52","author":"AJ Friedman","year":"1989","journal-title":"Fertility and sterility"},{"issue":"2","key":"ref100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0301-2115(00)00468-1","article-title":"The role of tamoxifen in the treatment of symptomatic uterine leiomyomata\u2014a pilot study","volume":"96","author":"O Sadan","year":"2001","journal-title":"European journal of obstetrics, gynecology, and reproductive biology"},{"issue":"6","key":"ref101","first-page":"343","article-title":"Short treatment with leuprolide acetate depot before hysterectomy for uterine leiomyomata","volume":"46","author":"R D'Anna","year":"1994","journal-title":"Minerva Ginecol"},{"issue":"2","key":"ref102","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1074-3804(05)60126-0","article-title":"Short-term administration of tibolone plus GnRH analog before laparoscopic myomectomy","volume":"9","author":"S Palomba","year":"2002","journal-title":"J Am Assoc Gynecol Laparoscopists"},{"issue":"1","key":"ref103","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.fertnstert.2007.05.061","article-title":"Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas","volume":"90","author":"S Palomba","year":"2008","journal-title":"Fertility and sterility"},{"issue":"3","key":"ref104","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0015-0282(16)57420-2","article-title":"Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment","volume":"63","author":"ME Fernandez-Mentoli","year":"1995","journal-title":"Fertility and sterility"},{"issue":"5","key":"ref105","first-page":"720","article-title":"Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study","volume":"77","author":"AJ Friedman","year":"1991","journal-title":"The Leuprolide Study Group. Obstetrics and gynecology"},{"issue":"1","key":"ref106","first-page":"477","article-title":"Treatment of symptomatic Uterine fibroids with green tea extract: A pilot randomized controlled clinical study","volume":"5","author":"E Roshdy","year":"2013","journal-title":"International Journal of Women's Health"},{"issue":"5","key":"ref107","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1471-0528.1990.tb01824.x","article-title":"Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence","volume":"97","author":"L Fedele","year":"1990","journal-title":"British journal of obstetrics and gynaecology"},{"issue":"3 Suppl 1","key":"ref108","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0015-0282(02)03551-3","article-title":"Treatment with the GnRH agonist (GnRHa) deslorelin (D) and low-dose add-back estradiol (E2) is effective in reducing pain, bleeding and uterine volume(UV) while maintaining bone mineral density (BMD) in women with symptomatic uterine fibroids (UF)","volume":"Vol 78","author":"A Daniels","year":"2002","journal-title":"Fertility & Sterility"},{"issue":"5","key":"ref109","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1471-0528.1994.tb11919.x","article-title":"Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids","volume":"101","author":"MA Lumsden","year":"1994","journal-title":"British journal of obstetrics and gynaecology"},{"issue":"7","key":"ref110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3109\/00016349509024390","article-title":"Trial of routine gonadotropin releasing hormone agonist treatment before abdominal hysterectomy for leiomyoma","volume":"74","author":"J Balasch","year":"1995","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"5","key":"ref111","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"J Donnez","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"ref112","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"J Donnez","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"4","key":"ref113","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1074-3804(98)80048-0","article-title":"Ultrasonographic prediction of the efficacy of GnRH agonist therapy before laparoscopic myomectomy","volume":"5","author":"F Zullo","year":"1998","journal-title":"The Journal of the American Association of Gynecologic Laparoscopists"},{"issue":"1","key":"ref114","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0378-5122(00)00159-6","article-title":"Uterine myoma in postmenopause: a comparison between two therapeutic schedules of HRT","volume":"37","author":"F Polatti","year":"2000","journal-title":"Maturitas"},{"issue":"9","key":"ref115","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/deq188","article-title":"The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial","volume":"25","author":"D Mavrelos","year":"2010","journal-title":"Human reproduction (Oxford, England)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0149631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T01:33:26Z","timestamp":1692236006000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0149631"}},"subtitle":[],"editor":[{"given":"Andrew","family":"Horne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,26]]},"references-count":115,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0149631","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,26]]}}}